Basel Medical Group Ltd Ordinary Shares (BMGL) Stock Price

BMGLStock

$4.80−78.95%52W

Market Cap$7.51M

P/E—

PEG Ratio—

Div yield—

Beta1.32

BMGL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-52.42%

Price vs S&P 500 (4W)-21.28%

VGM Score63.24

Book Value / Share (Quarterly)$3.16

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)2.03%

Cash Flow / Share (Quarterly)$-1.29

Price vs S&P 500 (YTD)-30.12%

Net Profit Margin (TTM)-53.48%

EPS (TTM)$-5.27

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-5.27

EPS (Annual)$-5.35

ROI (Annual)-101.17%

Cash / Share (Quarterly)$0.68

Revenue Growth QoQ (YoY)64.21%

ROA (Last FY)-56.94%

Revenue Growth TTM (YoY)29.84%

EBITD / Share (TTM)$-3.87

Operating Margin (TTM)-55.85%

Cash Flow / Share (Annual)$-2.31

P/B Ratio1.47x

P/B Ratio (Quarterly)1.88x

Net Income / Employee (Annual)$-119,643

Net Interest Coverage (TTM)-89.16x

ROA (TTM)-53.99%

EPS Incl Extra (Annual)$-5.35

Current Ratio (Annual)1.31x

Quick Ratio (Quarterly)1.84x

3-Month Avg Trading Volume0.04M

52-Week Price Return-78.95%

Revenue / Employee (TTM)$220,382

P/S Ratio (Annual)0.82x

Asset Turnover (Annual)0.61x

52-Week High$20.32

EPS Excl Extra (Annual)$-5.35

26-Week Price Return-41.18%

Quick Ratio (Annual)1.22x

13-Week Price Return-37.98%

Total Debt / Equity (Annual)0.93x

Current Ratio (Quarterly)1.88x

Enterprise Value$13.31M

Asset Turnover (TTM)1.01x

Revenue / Employee (Annual)$127,361

Pretax Margin (Annual)-97.65%

Cash / Share (Annual)$1.53

3-Month Return Std Dev144.51%

Net Income / Employee (TTM)$-117,831

ROE (Last FY)-195.70%

Net Interest Coverage (Annual)-31.23x

EPS Basic Excl Extra (Annual)$-5.35

P/FCF (TTM)3.70x

Receivables Turnover (TTM)3.22x

Total Debt / Equity (Quarterly)1.43x

EPS Incl Extra (TTM)$-5.27

Receivables Turnover (Annual)2.03x

ROI (TTM)-81.28%

P/S Ratio (TTM)0.47x

Revenue / Share (Annual)$5.70

Price vs S&P 500 (52W)-97.26%

Year-to-Date Return-18.37%

5-Day Price Return-7.69%

EPS Normalized (Annual)$-5.35

Net Profit Margin (Annual)-93.96%

Month-to-Date Return-14.59%

EBITD / Share (Annual)$-4.46

Operating Margin (Annual)-88.78%

LT Debt / Equity (Annual)0.00x

LT Debt / Equity (Quarterly)0.32x

EPS Basic Excl Extra (TTM)$-5.27

P/B Ratio (Annual)7.87x

Pretax Margin (TTM)-54.72%

Book Value / Share (Annual)$2.73

Price vs S&P 500 (13W)-40.78%

Beta1.32x

P/FCF (Annual)3.70x

Revenue / Share (TTM)$9.85

ROE (TTM)-178.85%

52-Week Low$3.28

vGradeA

gGradeA

mGradeF

vgmGradeB

Industry Peers — Physicians' Offices(12)

Symbol	Value Score	Growth Score	Momentum Score	Price
BMGLBasel Medical Group Ltd Ordinary Shares	A	A	F	$4.80
HIMSHims & Hers Health, Inc.	D	C	B	$31.75
TDOCTeladoc Health, Inc.	A	C	D	$6.19
STLNStarling Oncology, Inc. Common Stock	—	—	B	$6.30
TOIThe Oncology Institute, Inc. Common Stock	D	A	A	$5.13
SBCSBC Medical Group Holdings Incorporated Common Stock	B	F	B	$4.25
AUNAAuna S.A.	A	D	C	$5.28
AIRSAirSculpt Technologies, Inc. Common Stock	D	D	D	$2.67
LFMDLifeMD, Inc. Common Stock	C	C	F	$3.25
CCMConcord Medical Services Holding Limited	B	A	C	$4.95
SBCWWSBC Medical Group Holdings Incorporated Warrants	—	—	A	$0.32
STLNWStarling Oncology, Inc. Warrant	—	—	B	$0.07
TOIIWThe Oncology Institute, Inc. Warrant	—	—	C	$0.05

About Basel Medical Group Ltd Ordinary Shares

Basel Medical Group Ltd is a Singapore-based healthcare provider specializing in orthopedic, trauma, sports medicine, and neurosurgical services. The company operates multi-specialty clinics equipped with on-site surgical facilities, offering treatments including joint replacements, spine surgery, minimally invasive procedures, and general health services. Revenue is primarily generated from its Singapore operations.